Virtual reality offers new hope for comfort in final months
NCT ID NCT07545928
First seen Apr 25, 2026 · Last updated Jun 18, 2026 · Updated 10 times
Summary
This study tests whether using interactive virtual reality (VR) can help reduce pain, anxiety, and fatigue in 20 hospitalized palliative care patients. Unlike passive VR videos, patients can interact with a calming virtual environment by grabbing objects, which may improve their sense of control. The main goal is to see if patients can use the VR program daily for two weeks with good tolerance and no serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHOLOGICAL DISTRESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpitaux Universitaires de Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.